Ben Free

[KeckLab @keck_lab]

Congrats to @AleBonifazi for his new paper out now in @ACSChemNeurosci! https://t.co/DuFkMufawu

[BryanRoth @zenbrainest]

"our results suggest that ONC201 interacts with the D2R in a bitopic manner"

https://t.co/I6xXpf3QUp

[Ben Free @rbfree10]

Pharmacological characterization of the imipridone anti-cancer drug ONC201 reveals a negative allosteric mechanism of action at the D2 dopamine receptor https://t.co/luchf6SGqn

[Zachary Freyberg @zfreyberg]

Excited to share a new paper featuring the work of Despoina Aslanoglou and our many great collaborators! Pancreatic alpha cells & beta cells make dopamine to control insulin & glucagon release!
#diabetes #insulin
@PittResearch @PittPsychiatry @UPittEndo

https://t.co/HUkvx7T4od

[ACS Publications Bio & Med Chem Content @ACSBioMed]

Discovery and optimization of a selective D3 dopamine receptor agonist, ML417, as a therapeutic lead for neurological disorders @NIH @NINDSnews @UNCPharmacy @ncats_nih_gov @NIDAnews :
https://t.co/jrwPRsxMGi

[Ben Free @rbfree10]

@keck_lab @TheCalipariLab ACS now has a 'certified reviewer course' - if you take it / recommend to your students, they seem to send you a lot of reviews https://t.co/45aIKxazkj

[Washington Nationals @Nationals]

For those asking, just use #BryceIn12 once per tweet from 12p-4p. Counts the same. Use the rest of your characters to get people to RT!